Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Return on Capital Employed (2016 - 2025)

iBio (IBIO) has disclosed Return on Capital Employed for 15 consecutive years, with 0.44% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 41.0% to 0.44% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.44%, a 41.0% increase, with the full-year FY2025 number at 0.94%, down 40.0% from a year prior.
  • Return on Capital Employed was 0.44% for Q4 2025 at iBio, up from 0.54% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.18% in Q1 2021 to a low of 1.45% in Q4 2023.
  • A 5-year average of 0.74% and a median of 0.61% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: plummeted -109bps in 2023, then soared 95bps in 2024.
  • iBio's Return on Capital Employed stood at 0.23% in 2021, then crashed by -276bps to 0.88% in 2022, then crashed by -65bps to 1.45% in 2023, then surged by 42bps to 0.85% in 2024, then skyrocketed by 48bps to 0.44% in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Return on Capital Employed are 0.44% (Q4 2025), 0.54% (Q3 2025), and 1.24% (Q2 2025).